The role of COVID-19 vaccines in preventing post-COVID-19 thromboembolic and cardiovascular complications.

Núria Mercadé-BesoraXintong LiRaivo KoldeNhung Th TrinhMaria T Sanchez-SantosWai Yi ManElena RoelCarlen ReyesAntonella DelmestriHedvig M E NordengAnneli Uuskula Talita Duarte SallesClara PratsDaniel Prieto Alhambra Annika M JödickeMartí Català

Published in: Heart (British Cardiac Society) (2024)

COVID-19 vaccination reduced the risk of post-COVID-19 cardiac and thromboembolic outcomes. These effects were more pronounced for acute COVID-19 outcomes, consistent with known reductions in disease severity following breakthrough versus unvaccinated SARS-CoV-2 infection.

Keyphrases

coronavirus disease
sars cov
respiratory syndrome coronavirus
liver failure
left ventricular
metabolic syndrome
adipose tissue
skeletal muscle
respiratory failure
hepatitis b virus
drug induced
acute respiratory distress syndrome
mechanical ventilation